Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Other pharmaceutical and health care companies recently announced layoffs — including Bayer, Siemens, RWJBarnabas Health and Bristol Myers Squibb — as they struggled to integrate AI On March 11, ...

The Swiss medication giant reported three meetings with federal officials in the past week, two of which were with Health ...

Swiss pharmaceutical company, Novartis, has announced plans to build a new, $1.1 billion biomedical research complex in San ...